VectivBio (VECT) Institutional Ownership $16.85 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for VectivBio (NASDAQ:VECT)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$8.09MNumber ofInstitutional Sellers(last 12 months)0 Get VECT Insider Trade Alerts Want to know when executives and insiders are buying or selling VectivBio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VECT Institutional Buying and Selling by Quarter Ad Crypto 101 MediaThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… VectivBio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/23/2024 Regency Capital Management Inc. DE510,000$8.59M5.5%+1,600.0%0.000% 8/22/2023CHI Advisors LLC2,782,756$46.95M14.2%-47.1%0.000% 8/14/2023Ergoteles LLC443,928$7.49M0.4%N/A0.000% 8/14/2023 EHP Funds Inc.170,000$2.87M0.7%N/A0.000% 8/14/2023 Hunting Hill Global Capital LLC63,581$1.07M0.3%N/A0.000% 8/14/2023 Prelude Capital Management LLC219,643$3.71M0.2%N/A0.000% Get the Latest News and Ratings for VECT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VectivBio and its competitors with MarketBeat's FREE daily newsletter. 8/14/2023 Chicago Capital Management LLC173,840$2.96M3.8%N/A0.000% 8/11/2023 Hsbc Holdings PLC562,022$9.48M0.0%N/A0.000% 8/10/2023 Gardner Lewis Asset Management L P642,769$10.84M3.9%N/A1.889% 8/10/2023 Alpine Associates Management Inc.1,806,697$30.71M1.4%N/A5.311% 8/7/2023 Wolverine Asset Management LLC33,426$564K0.0%N/A0.000% 8/7/2023 Versor Investments LP1,210,379$20.42M3.5%N/A0.000% 8/7/2023 New York Life Investment Management LLC135,051$2.28M0.0%N/A0.000% 8/3/2023 Picton Mahoney Asset Management100,000$1.70M0.1%N/A0.000% 8/1/2023 Regency Capital Management Inc. DE30,000$506K0.4%-21.1%0.000% 7/27/2023 Virtu Financial LLC41,411$699K0.1%N/A0.000% 7/27/2023 GAM Holding AG27,545$465K0.0%N/A0.000% 7/20/2023 Harvest Management LLC45,817$779K0.7%N/A0.135% 7/20/2023 Exchange Traded Concepts LLC8,512$144K0.0%N/A0.000% 5/11/2023CHI Advisors LLC5,255,484$44.72M11.9%-4.3%0.000% 5/10/2023Tekla Capital Management LLC682,834$5.87M0.2%-7.4%0.000% 5/8/2023 Regency Capital Management Inc. DE38,000$323K0.4%N/A0.000% 2/14/2023 VR Adviser LLC1,866,000$16.17M2.6%N/A5.487% 2/14/2023 Driehaus Capital Management LLC1,716,656$14.78M0.2%+100.8%5.048% 2/13/2023 Vivo Capital LLC2,333,300$20.22M2.3%N/A6.861% 2/10/2023Tekla Capital Management LLC737,704$6.35M0.2%-2.5%2.169% 2/8/2023 UBS Group AG253,877$2.20M0.0%-2.4%0.746% 2/3/2023 Frazier Life Sciences Management L.P.1,333,400$11.48M0.7%N/A3.920% 11/15/2022 Citadel Advisors LLC3,145,251$18.87M0.0%+0.1%9.248% 11/14/2022 Cormorant Asset Management LP2,536,617$15.22M1.1%-10.7%7.457% 11/14/2022 Caxton Corp140,863$845K1.6%-27.6%0.414% 11/3/2022 Barclays PLC7,807$47K0.0%N/A0.023% 10/13/2022 National Bank of Canada FI165,333$992K0.0%N/A0.486% 8/16/2022 Driehaus Capital Management LLC865,229$4.67M0.1%+120.0%2.544% 8/15/2022 Caxton Corp194,577$1.05M1.4%N/A0.572% 2/3/2022 Canaan Partners XI LLC37,051$182K0.0%N/A0.109% 11/16/2021CHI Advisors LLC2,592,602$20.03M5.8%+0.3%7.622% 11/16/2021 Citadel Advisors LLC2,721,363$20.73M0.0%-0.2%8.000% 11/15/2021 Caas Capital Management LP22,565$174K0.0%-45.1%0.066% 8/17/2021 Woodline Partners LP86,596$1.01M0.0%N/A0.255% Your chance to get on the next “60-Second Trade” (Ad)Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here!8/17/2021 Millennium Management LLC95,214$1.11M0.0%N/A0.280% 8/17/2021 PFM Health Sciences LP611,074$7.13M0.2%N/A1.796% 8/17/2021 Caas Capital Management LP41,096$479K0.0%N/A0.121% 8/17/2021 Citadel Advisors LLC2,725,767$31.24M0.0%N/A8.013% 8/16/2021 Squarepoint Ops LLC25,000$292K0.0%N/A0.073% 8/16/2021Pinz Capital Management LP30,561$356K0.1%N/A0.090% 8/13/2021 Northern Trust Corp7,159$83K0.0%N/A0.021% 8/13/2021Tekla Capital Management LLC145,000$1.69M0.1%N/A0.426% 8/13/2021 Geode Capital Management LLC17,780$207K0.0%N/A0.052% 8/12/2021 Monashee Investment Management LLC54,466$635K0.1%N/A0.160% 8/11/2021CHI Advisors LLC2,585,986$30.15M7.0%N/A7.602% (Data available from 1/1/2016 forward) VECT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VECT shares? During the previous two years, 24 institutional investors and hedge funds held shares of VectivBio. The most heavily invested institutionals were CHI Advisors LLC ($46.95M), Alpine Associates Management Inc. ($30.71M), Versor Investments LP ($20.42M), Vivo Capital LLC ($20.22M), VR Adviser LLC ($16.17M), Driehaus Capital Management LLC ($14.78M), and Frazier Life Sciences Management L.P. ($11.48M).Learn more on VECT's institutional investors. Which institutional investors have been buying VectivBio stock? Of the 21 institutional investors that purchased VectivBio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vivo Capital LLC ($2.33M), VR Adviser LLC ($1.87M), Alpine Associates Management Inc. ($1.81M), Frazier Life Sciences Management L.P. ($1.33M), Versor Investments LP ($1.21M), Driehaus Capital Management LLC ($861.92K), and Gardner Lewis Asset Management L P ($642.77K). How much institutional buying is happening at VectivBio? Institutional investors have bought a total of 12,597,242 shares in the last 24 months. This purchase volume represents approximately $159.72M in transactions. Which VectivBio major shareholders have been selling company stock? The following institutional investors have sold VectivBio stock in the last 24 months: CHI Advisors LLC ($2.71M), Tekla Capital Management LLC ($73.67K), Regency Capital Management Inc. DE ($8K), and UBS Group AG ($6.29K). How much institutional selling is happening at VectivBio? Institutional investors have sold a total of 2,798,095 shares in the last 24 months. This volume of shares sold represents approximately $44.55M in transactions. Related Companies NAMS Major Shareholders IDYA Major Shareholders CNTA Major Shareholders RXRX Major Shareholders IBRX Major Shareholders APGE Major Shareholders WVE Major Shareholders AKRO Major Shareholders MIRM Major Shareholders TARS Major Shareholders This page (NASDAQ:VECT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VectivBio Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share VectivBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
